Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 0.8275 USD -7.75%
Market Cap: 7.8m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Trinity Biotech PLC
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Trinity Biotech PLC
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Trinity Biotech PLC
NASDAQ:TRIB
Net Income (Common)
-$20.3m
CAGR 3-Years
-37%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Medtronic PLC
NYSE:MDT
Net Income (Common)
$4.3B
CAGR 3-Years
-3%
CAGR 5-Years
-2%
CAGR 10-Years
4%
STERIS plc
NYSE:STE
Net Income (Common)
$434.8m
CAGR 3-Years
20%
CAGR 5-Years
5%
CAGR 10-Years
13%
No Stocks Found

Trinity Biotech PLC
Glance View

Market Cap
7.8m USD
Industry
Health Care

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

TRIB Intrinsic Value
8.1873 USD
Undervaluation 90%
Intrinsic Value
Price

See Also

What is Trinity Biotech PLC's Net Income (Common)?
Net Income (Common)
-20.3m USD

Based on the financial report for Sep 30, 2024, Trinity Biotech PLC's Net Income (Common) amounts to -20.3m USD.

What is Trinity Biotech PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
7%

Over the last year, the Net Income (Common) growth was 29%. The average annual Net Income (Common) growth rates for Trinity Biotech PLC have been -37% over the past three years , 7% over the past five years .

Back to Top